• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Post-exertional malaise as an outcome measure in any ME/CFS trials?

Tom Kindlon

Senior Member
Messages
1,734
I found this:


The Fatigue score was calculated every second week as the mean of the four symptoms: Fatigue, Post-exertional malaise, Need for rest, Daily functioning.

Fluge Ø, Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, et al. (2015) B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment. PLoS ONE 10(7): e0129898. doi:10.1371/journal.pone.0129898
 

Tom Kindlon

Senior Member
Messages
1,734
I said they are interested in "trials"; another term is "interventional studies". So studies that measured post-exertional symptoms before and after a treatment of any sort, most likely a questionnaire.

The Rituximab study I found I'm guessing isn't going to be suitable as it is only part of the measure.